Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYanık A.
dc.contributor.authorKaplan Ö.
dc.contributor.authorAksan G.
dc.contributor.authorDağaşan G.
dc.contributor.authorSünter A.T.
dc.contributor.authorYüksel S.
dc.contributor.authorDemircan S.
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:52:54Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:52:54Z
dc.date.issued2017
dc.identifier.issn1309-0720
dc.identifier.urihttps://dx.doi.org/10.4328/JCAM.4927
dc.identifier.urihttp://hdl.handle.net/11446/1767
dc.description.abstractAim: In this study we have used quantitative coronary angiography (QCA) and the Image J program in order to investigate the influence of plaque area, as identified prior to stent implantation, on the development of stent restenosis. Material and Method: 5180 coronary angiography procedures were performed between March 2008 and July 2011. Of these, 227 presented with in-stent restenosis. After application of the exclusion criteria, 164 intracor-onary stents implanted in 121 patients were retrospectively investigated. These stents were divided into two groups depending upon the clinical status of the patient: (a) those who developed in-stent restenosis (n: 77, 47%), and (b) those who failed to develop in-stent restenosis (n: 87, 53%). Narrowing by 50% or more, as identified during coronary angiography performed at least six months after the stent implantation, was considered as positive for development of in-stent restenosis. Plaque area measurement in the patients was performed using quantitative coronary angiography (QCA) and the Image J program. Results: Plaque area measurement when performed quantitatively revealed no statistically significant difference between the groups (p>0.05). However, significant difference in area was observed when Image J was used (p<0.05). Statistically significant differences were observed between groups in terms of history of hypertension and hyperlipidemia, use of statins, HDL values, and lesion type (p<0.05); the difference in terms of presence of diabetes or smoking status (p>0.05) was not significant. There was a relationship among the development of restenosis and hypertension, non-usage of statin therapy, HDL level, poor lesion type, and plaque area as measured with Image J. Discussion: Hypertension, non-usage statin therapy, low levels of HDL, poor lesion type, and larger plaque areas as measured with the Image J program were identified as important indicators for development of in-stent restenosis. © Derman Medical Publishing. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherDerman Medical Publishingen_US
dc.identifier.doi10.4328/JCAM.4927en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectImage Jen_US
dc.subjectIn-Stent Restenosisen_US
dc.subjectPlaque Areaen_US
dc.titleImpact of pre-stent implantation plaque burden on the development of stent restenosis [Stent implantasyonu öncesindeki plak yükünün stent restenozuna olan etkisi]en_US
dc.typearticleen_US
dc.relation.journalJournal of Clinical and Analytical Medicineen_US
dc.departmentDBÜen_US
dc.identifier.volume8en_US
dc.identifier.startpage84en_US
dc.identifier.endpage89en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempDBÜen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster